logo
[breadcrumb_custom]

Tag: NASDAQ:AGRX

Finance

AGRX’s Market Quandary: Decoding the Ups and Downs of 2023

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price decrease of -72.15%. However, over the past six months, we’ve seen a stronger performance of -73.25%. The price of AGRX leaped by -54.75% over the last 30 days. And in the last five days, it has fallen by -27.11%. Agile Therapeutics Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock

VIPS stock
Finance

Agile Therapeutics Inc (AGRX) Stock: Navigating Market Highs and Lows in 52 Weeks

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Agile Therapeutics Inc’s current trading price is -94.79% away from its 52-week high, while its distance from the 52-week low is 7.86%. The stock’s price range for this period has been between $0.70 and $14.50 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 12.01 million for the day, a number notably higher than the average daily volume of 0.36 million over the last three months. Agile Therapeutics Inc saw a rather unpredictable

ZM Stock
Finance

Agile Therapeutics Inc (AGRX) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Agile Therapeutics Inc’s current trading price is -92.89% away from its 52-week high, while its distance from the 52-week low is 8.45%. The stock’s price range over this period has fluctuated between $0.95 and $14.50. The company, operating within the financial sector, had a trading volume of approximately 13.09 million for the day, which was noticeably higher than the average daily share volume of 78990.0 over the last 3 months. In terms of market performance, Agile Therapeutics